Gold opportunities in the Abitibi Greenstone Belt – EquityGuru
Greg Nolan does a great job running through a dozen explorers and development companies in the Abitibi.
Year: 2019
FSD Pharma Enters into Supply Agreement with Canntab Therapeutics and World Class Extractions on Organic Hemp Deal
– FSD enters into 3-way supply agreement to purchase up to 1,000 kg of 2018 hemp crop –
FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD”), a licensed producer under the Cannabis Act, announced today that it has entered into a supply agreement (the “Agreement”) with Canntab Therapeutics Ltd. (“Canntab”) and World Class Extractions Inc. (“World Class”) (the “Purchasers”) to purchase hemp flower from Thomas Elcome (the “Supplier”). Pursuant to the agreement, the Purchasers have agreed to buy approximately 1,000 kg of the Supplier’s 2018 hemp crop at a purchase price of $100.00 per kg per 1% of CBD extracted from the flower.
Millennial Reports Positive Pumping Test Results from Second Pumping Well at Pastos Grandes Project, Argentina
Millennial Lithium Corp. (TSXV: ML) (“Millennial” or the “Company”) is pleased to report encouraging results from an extended pumping test of a second production-scale well at its Pastos Grandes Project in Salta, Argentina. Pumping well PGPW17-04 was installed to complete extended pumping of lithium brine to determine the robustness and chemical variation of the aquifer over 23 days in September, 2018. At a pumping rate of 15 litres/second (L/s), the lithium content remained consistent over the trial period and the drawdown was approximately 57 metres (m), with rapid recovery. Estimated transmissivity was calculated from the drawdown data at 40m2/day. The pumping test was completed under the direction and supervision of Montgomery and Associates.
Cannara Biotech Shares to Begin Trading on the Frankfurt Exchange
Cannara Biotech Inc. (“Cannara Biotech” or the “Company”) (CSE: LOVE) (FRA: 8CB), a vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced its common shares are listed for trading on the Frankfurt Stock Exchange under the trading symbol “8CB”. The Company’s common shares continue to be listed on the Canadian Securities Exchange under the trading symbol “LOVE”.
FSD Pharma responds to and corrects misleading Auxly claims
FSD Pharma Inc.(CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) a licensed producer under the Cannabis Act, responded today to a press release by its former partner, Auxly Cannabis Group Inc. (“Auxly”) to correct misleading claims.
Rules for Value Investors – Seth Klarman
The junior resource world is, in my humble opinion, all about entry point. Buying when everyone else is selling and then holding on until the story actually resolves itself.
Aben Resources Grants Stock Options
Aben Resources Ltd. (TSX-V: ABN) (OTCQB: ABNAF) (Frankfurt: E2L2) (the “Company”) announces, pursuant to its stock option plan, the Company has granted incentive stock options to its directors, officers, employees and consultants to purchase up to an aggregate of 4,000,000 common shares in the capital stock of the Company, exercisable for a period of two years, at a price of $0.16 per share. The Company’s 10% rolling stock option plan was approved by the shareholders at the Annual General Meeting of the Company held on July 25, 2018.
Cannara Biotech Enters Cannabinoid-Infused Beverage Product Category
Partners with a Leading Quebec MicrobreweryCannara Biotech Inc. (“Cannara Biotech” or the “Company”) (CSE: LOVE), a Montreal-based company that is building a vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced it has entered into a letter of intent with a leading Quebec microbrewery to develop cannabinoid-infused beverages. Following the regulations relating to edibles and beverages coming into effect next October, consumers will be able to purchase a variety of cannabinoid-infused beverages including non-alcoholic beer, kombucha and cider.